225 related articles for article (PubMed ID: 35223450)
1. Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis.
Xu J; Xu L; Wang B; Kong W; Chen Y; Yu Z
Front Oncol; 2021; 11():766148. PubMed ID: 35223450
[TBL] [Abstract][Full Text] [Related]
2. EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.
Marcoux N; Gettinger SN; O'Kane G; Arbour KC; Neal JW; Husain H; Evans TL; Brahmer JR; Muzikansky A; Bonomi PD; Del Prete S; Wurtz A; Farago AF; Dias-Santagata D; Mino-Kenudson M; Reckamp KL; Yu HA; Wakelee HA; Shepherd FA; Piotrowska Z; Sequist LV
J Clin Oncol; 2019 Feb; 37(4):278-285. PubMed ID: 30550363
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma.
Wang S; Xie T; Hao X; Wang Y; Hu X; Wang L; Li Y; Li J; Xing P
Thorac Cancer; 2021 Oct; 12(19):2585-2593. PubMed ID: 34490724
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
Wang W; Xu C; Chen H; Jia J; Wang L; Feng H; Wang H; Song Z; Yang N; Zhang Y
Lung Cancer; 2021 May; 155():20-27. PubMed ID: 33714778
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.
Roca E; Gurizzan C; Amoroso V; Vermi W; Ferrari V; Berruti A
Cancer Treat Rev; 2017 Sep; 59():117-122. PubMed ID: 28806542
[TBL] [Abstract][Full Text] [Related]
6. Novel ETV1 mutation in small cell lung cancer transformation resistant to EGFR tyrosine kinase inhibitors.
Zhou Y; Bai H; Xia J; Xu WY; Cheng L; Xiong L
Ann Transl Med; 2021 Jul; 9(14):1150. PubMed ID: 34430591
[TBL] [Abstract][Full Text] [Related]
7. Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: a case report and systematic review.
Zhang C; Lin L; Guo X; Chen P
Transl Cancer Res; 2020 May; 9(5):3725-3733. PubMed ID: 35117735
[TBL] [Abstract][Full Text] [Related]
8. EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer.
Sonoda T; Nishikawa S; Sakakibara R; Saiki M; Ariyasu R; Koyama J; Kitazono S; Yanagitani N; Horiike A; Ohyanagi F; Ninomiya H; Ishikawa Y; Nishio M
Respir Med Case Rep; 2018; 24():19-21. PubMed ID: 29977749
[TBL] [Abstract][Full Text] [Related]
9. Case report: EGFR-mutant lung adenocarcinoma with the TP53 and RB1 mutations showed resistance to TKI therapy.
Lu Y; Li Z; Zhu H; Zhao J; Xu M; Gu W
Ann Palliat Med; 2021 Dec; 10(12):12886-12893. PubMed ID: 35016432
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
Santoni-Rugiu E; Grauslund M; Melchior LC; Costa JC; Sørensen JB; Urbanska EM
Lung Cancer; 2017 Nov; 113():14-17. PubMed ID: 29110841
[TBL] [Abstract][Full Text] [Related]
11. Expression of
Zhang SL; Zhang CY; Chen YQ; Li YF; Xie Z; Zhang XC; Zhou Q; Zhong WZ; Huang J; Sun H; Zheng MY; Xiao FM; Yan HH; Lu DX; Lv ZY; Wu YL; Chen HJ; Yang JJ
J Thorac Dis; 2023 Sep; 15(9):4620-4635. PubMed ID: 37868836
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and molecular characteristics of
Yu L; Bazhenova L; Gold K; Tran L; Hilburn V; Vu P; Patel SP
Transl Lung Cancer Res; 2022 Mar; 11(3):452-461. PubMed ID: 35399568
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of acquired T790M mutation and small cell lung cancer transformation in a patient with EGFR-mutant adenocarcinoma after first- and third-generation EGFR-TKIs: a case report.
Ma S; He Z; Fu H; Wang L; Wu X; Zhang Z; Wang Q
Transl Lung Cancer Res; 2020 Feb; 9(1):139-143. PubMed ID: 32206560
[TBL] [Abstract][Full Text] [Related]
14. Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study.
Ding J; Leng Z; Gu H; Jing X; Song Y
Front Oncol; 2023; 13():1153131. PubMed ID: 37361601
[TBL] [Abstract][Full Text] [Related]
15. Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer.
Mambetsariev I; Arvanitis L; Fricke J; Pharaon R; Baroz AR; Afkhami M; Koczywas M; Massarelli E; Salgia R
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268520
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer.
Yang H; Liu L; Zhou C; Xiong Y; Hu Y; Yang N; Qu J
Medicine (Baltimore); 2019 Mar; 98(12):e14893. PubMed ID: 30896637
[TBL] [Abstract][Full Text] [Related]
17. Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations.
Hayashi H; Nadal E; Gray JE; Ardizzoni A; Caria N; Puri T; Grohe C
Clin Lung Cancer; 2022 Jan; 23(1):e69-e82. PubMed ID: 34865963
[TBL] [Abstract][Full Text] [Related]
18. Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases.
Ahn S; Hwang SH; Han J; Choi YL; Lee SH; Ahn JS; Park K; Ahn MJ; Park WY
J Pathol Transl Med; 2016 Jul; 50(4):258-63. PubMed ID: 27160687
[TBL] [Abstract][Full Text] [Related]
19. Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP).
Cardona AF; Arrieta O; Zapata MI; Rojas L; Wills B; Reguart N; Karachaliou N; Carranza H; Vargas C; Otero J; Archila P; Martín C; Corrales L; Cuello M; Ortiz C; Pino LE; Rosell R; Zatarain-Barrón ZL;
Target Oncol; 2017 Aug; 12(4):513-523. PubMed ID: 28620690
[TBL] [Abstract][Full Text] [Related]
20. Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients.
Kuiper JL; Heideman DA; Thunnissen E; Paul MA; van Wijk AW; Postmus PE; Smit EF
Lung Cancer; 2014 Jul; 85(1):19-24. PubMed ID: 24768581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
